NewAmsterdam Short Long Term Debt vs Current Deferred Revenue Analysis

NAMS Stock   26.19  7.67  41.41%   
NewAmsterdam Pharma financial indicator trend analysis is infinitely more than just investigating NewAmsterdam Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NewAmsterdam Pharma is a good investment. Please check the relationship between NewAmsterdam Pharma Short Long Term Debt and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

Short Long Term Debt vs Current Deferred Revenue

Short Long Term Debt vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NewAmsterdam Pharma Short Long Term Debt account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between NewAmsterdam Pharma's Short Long Term Debt and Current Deferred Revenue is -0.55. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of NewAmsterdam Pharma, assuming nothing else is changed. The correlation between historical values of NewAmsterdam Pharma's Short Long Term Debt and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of NewAmsterdam Pharma are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Short Long Term Debt i.e., NewAmsterdam Pharma's Short Long Term Debt and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.55
Relationship DirectionNegative 
Relationship StrengthVery Weak

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from NewAmsterdam Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NewAmsterdam Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.Tax Provision is likely to gain to about 28.4 K in 2024, whereas Selling General Administrative is likely to drop slightly above 13.5 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense216K271K6.8M7.1M
Depreciation And Amortization4.4K8.4K49K51.5K

NewAmsterdam Pharma fundamental ratios Correlations

-0.830.750.891.00.820.7-0.98-0.750.891.00.770.831.00.560.070.80.931.00.78-0.481.00.771.0-0.830.77
-0.83-0.78-0.74-0.83-1.0-0.960.870.8-0.93-0.84-0.45-1.0-0.84-0.660.48-0.94-0.77-0.82-0.940.62-0.84-0.51-0.851.0-0.51
0.75-0.780.890.730.830.57-0.85-1.00.870.790.170.780.790.97-0.050.570.870.730.55-0.910.790.170.77-0.780.17
0.89-0.740.890.870.770.53-0.91-0.90.920.920.430.740.920.780.120.561.00.870.55-0.630.920.420.9-0.740.42
1.0-0.830.730.870.820.71-0.98-0.740.880.990.790.830.990.530.070.810.911.00.79-0.460.990.791.0-0.830.79
0.82-1.00.830.770.820.93-0.88-0.850.940.840.41.00.840.72-0.450.920.780.810.91-0.680.840.460.84-1.00.46
0.7-0.960.570.530.710.93-0.73-0.60.810.70.450.960.70.45-0.650.980.570.70.98-0.440.710.540.72-0.960.54
-0.980.87-0.85-0.91-0.98-0.88-0.730.85-0.93-0.99-0.66-0.87-0.99-0.69-0.02-0.8-0.94-0.98-0.790.63-0.99-0.66-0.990.87-0.66
-0.750.8-1.0-0.9-0.74-0.85-0.60.85-0.9-0.8-0.17-0.8-0.8-0.960.09-0.59-0.88-0.73-0.580.9-0.8-0.17-0.780.8-0.17
0.89-0.930.870.920.880.940.81-0.93-0.90.920.440.930.920.76-0.240.80.930.870.8-0.630.920.470.92-0.930.47
1.0-0.840.790.920.990.840.7-0.99-0.80.920.710.841.00.610.060.780.950.990.77-0.521.00.721.0-0.840.72
0.77-0.450.170.430.790.40.45-0.66-0.170.440.710.450.71-0.090.240.620.510.790.610.10.720.990.73-0.450.99
0.83-1.00.780.740.831.00.96-0.87-0.80.930.840.450.840.66-0.480.950.760.820.94-0.610.840.520.85-1.00.52
1.0-0.840.790.920.990.840.7-0.99-0.80.921.00.710.840.610.060.780.950.990.77-0.521.00.721.0-0.840.72
0.56-0.660.970.780.530.720.45-0.69-0.960.760.61-0.090.660.61-0.10.40.750.530.39-0.950.61-0.090.59-0.66-0.09
0.070.48-0.050.120.07-0.45-0.65-0.020.09-0.240.060.24-0.480.06-0.1-0.490.130.09-0.510.10.050.120.040.480.12
0.8-0.940.570.560.810.920.98-0.8-0.590.80.780.620.950.780.4-0.490.620.81.0-0.410.790.690.8-0.950.69
0.93-0.770.871.00.910.780.57-0.94-0.880.930.950.510.760.950.750.130.620.910.6-0.610.950.50.94-0.760.5
1.0-0.820.730.871.00.810.7-0.98-0.730.870.990.790.820.990.530.090.80.910.78-0.460.990.791.0-0.810.79
0.78-0.940.550.550.790.910.98-0.79-0.580.80.770.610.940.770.39-0.511.00.60.78-0.40.770.690.79-0.940.69
-0.480.62-0.91-0.63-0.46-0.68-0.440.630.9-0.63-0.520.1-0.61-0.52-0.950.1-0.41-0.61-0.46-0.4-0.520.1-0.510.610.1
1.0-0.840.790.920.990.840.71-0.99-0.80.921.00.720.841.00.610.050.790.950.990.77-0.520.721.0-0.840.72
0.77-0.510.170.420.790.460.54-0.66-0.170.470.720.990.520.72-0.090.120.690.50.790.690.10.720.74-0.521.0
1.0-0.850.770.91.00.840.72-0.99-0.780.921.00.730.851.00.590.040.80.941.00.79-0.511.00.74-0.840.74
-0.831.0-0.78-0.74-0.83-1.0-0.960.870.8-0.93-0.84-0.45-1.0-0.84-0.660.48-0.95-0.76-0.81-0.940.61-0.84-0.52-0.84-0.52
0.77-0.510.170.420.790.460.54-0.66-0.170.470.720.990.520.72-0.090.120.690.50.790.690.10.721.00.74-0.52
Click cells to compare fundamentals

NewAmsterdam Pharma Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.